[1]SANZ M, MARCO DEL CASTILLO A, JEPSEN S, et al..1.Periodontitis and cardiovascular diseases: Consensus report[J/OL]. Journal of Clinical Periodontology, 2020, 47(3): 268-288. DOI:10.1111/jcpe.13189.[2]TEUGHELS W, FERES M, OUD V, et al. 4.Adjunc-tive effect of systemic antimicrobials in periodontitis therapy: A systematic review and meta-analysis[J/OL]. Journal of Clinical Periodontology, 2020, 47 Suppl 22: 257-281. DOI:10.1111/jcpe.13264.[3]ZHOU K, XIE J, SU Y, et al.. 6.Lactobacillus reuteri for chronic periodontitis: focus on underlying mechanisms and future perspectives[J/OL]. Biotechnology & Genetic Engineeri-ng Reviews, 2023: 1-28. DOI:10.1080/02648725.2023.2183617.[4]MOMAN R, O’NEILL C A, LEDDER R G, et al.. 8.Mitigation of the Toxic Effects of Periodontal Pathogens by Candidate Probiotics in Oral Keratinocytes, and in an Invertebrate Model[J/OL]. Frontiers in Microbiology, 2020, 11: 999. DOI:10.3389/fmicb.2020.00999.[5]MORAES R M, LESCURA C M, MILHAN N V M, et al.. 11.Live and heat-killed Lactobacillus reuteri reduce alveolar bone loss on induced periodontitis in rats[J/OL]. Archives of Oral Biology, 2020, 119: 104894. DOI:10.1016/j.archoralbio.2020.104894.[6]MANRESA C, SANZ-MIRALLES E C, TWIGG J, et al.. 14.Supportive periodontal therapy (SPT) for maintaining the dentition in adults treated for periodontitis[J/OL]. The Cochrane Database of Systematic Reviews, 2018, 1(1): CD009376. DOI:10.1002/14651858.CD009376.pub2
